Innovation in high risk drug therapy.
The aim of this study was to identify predictors of the early adoption of high risk drugs by specialists with the expectation that the processes of innovation in this domain differ from those identified for general medical practice.
One hundred and fifty-six specialists provided information regarding their awareness and use of each of eight target drugs, selected for their riskiness, and discussed in detail their adoption of one of them.
General innovative behaviour, as assessed by awareness and use of the target drugs, as well as early first news of the particular drug discussed, were predictable from formal and informal contact with colleagues.
Mots-clés Pascal : Médecin, Personnel sanitaire, Spécialité médicale, Prescription médicale, Médicament, Innovation, Risque élevé, Comportement, Prise conscience, Homme, Prédiction, Pratique professionnelle, Australie, Océanie
Mots-clés Pascal anglais : Physician, Health staff, Medical specialty, Medical prescription, Drug, Innovation, High risk, Behavior, Awareness, Human, Prediction, Professional practice, Australia, Oceania
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0459353
Code Inist : 002B30A05. Création : 199406.